Abiraterone letter to editor15 Mar 2012 Dear Sir, March is Prostate Cancer Awareness Month. In a few weeks time NICE will meet to discuss the responses to their draft decision not to recommend abiraterone, a life extending drug for men with incurable prostate cancer. Read more
Charity warns “short sighted” NICE risks compromising care of men with prostate cancer14 Mar 2012 Men with prostate cancer are at risk of being left behind those with other common cancers thanks to a spate of recent moves by the National Institute for Health and Clinical Excellence (NICE), The Prostate Cancer Charity has warned. Read more
The Prostate Cancer Charity criticises SMC abiraterone decision12 Mar 2012 We have criticised the Scottish Medicines Consortium's (SMC) decision not to recommend abiraterone for use on the NHS in Scotland. It follows the National Institute for Health and Clinical Excellence's (NICE) draft decision to deny the drug for men on the NHS in England and Wales. Read more